Massachusetts General Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts General Hospital sits in the top decile of US sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count).
Massachusetts General Hospital: 2,032 sponsored US clinical trials, 336 recruiting.
Massachusetts General Hospital sponsors 2,032 registered US clinical trials on ClinicalTrials.gov, 336 of them currently recruiting, and 1,284 completed. 240 of these trials are in Phase 3-4 (later-stage) and 515 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 29 trials.
Top-decile sponsor footprint
Massachusetts General Hospital ranks in the top decile of sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,032 total, page 33 of 41
Using Video Images to Improve Advance Care Planning in Patients With Cancer
NCT00970125
Duloxetine for Menopausal Depression
NCT01117857
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
NCT00976898
Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults
NCT01439035
A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects
NCT00833781
Treatment of Older Adults With Acute Lymphoblastic Leukemia
NCT00973752
D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
NCT00963924
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
NCT00948688
Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer
NCT00959985
Optical Frequency Domain Imaging for Assessing Colonic Polyps
NCT01439087
High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
NCT00895661
Direct to Smoker Outreach in a Health Care Setting
NCT01321944
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
NCT00833976
Kisspeptin Administration in the Adult
NCT00914823
fMRI Study of Expectancy on Acupuncture Treatment Outcomes in Knee OA
NCT01040754
Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
NCT00926380
Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder
NCT01002326
A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection
NCT01091077
Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
NCT01411150
Different Vitamin D Preparations & FGF23 in Humans
NCT00957879
Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes
NCT00946192
Two Approaches to Routine HIV Testing in a Hospital Emergency Department
NCT01258582
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT00869999
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
NCT00842257
Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
NCT00888628
Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD
NCT02136745
Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
NCT00722761
Metabolome and Microbiomic in Fecal Samples
NCT00938028
Relaxation Response Training to Treat Hypertension
NCT01263743
Using Videos in Advance Care Planning for Patients With Advanced Cancer
NCT01241929
Effect of Inpatient Diabetes Management on Outpatient Glycemic Control
NCT00869362
Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
NCT00865644
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
NCT00869479
Efficacy of Structured Insulin Order
NCT01130558
Optical Frequency Domain Imaging (OFDI) for Biliary Stricture Imaging
NCT01439620
Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men
NCT00850564
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy
NCT01097733
PCI-24781 in Combination With Doxorubicin to Treat Sarcoma
NCT01027910
Diabetes Connect: Patients and Providers Use of a Secure Website for Blood Glucose Monitoring in Type-2 Diabetes
NCT00812539
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
NCT00823901
Effects of Short-term Growth Hormone in HIV-infected Patients
NCT00795210
Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer
NCT00836342
Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety
NCT01551303
EASI Access II --- Follow-up Study to the EASI Access Trial
NCT00740727
Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder
NCT00879320
Does Mindfulness Training Change the Processing of Social Threat?
NCT00992875
Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)
NCT00916630
Effectiveness of Telepsychiatry-based Culturally Sensitive Collaborative Treatment of Depressed Chinese Americans
NCT00854542
Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major Depression
NCT00961454
Escitalopram (Lexapro) for the Treatment of Postpartum Depression
NCT00833469
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 226 |
| Phase 2 | 289 |
| Phase 3 | 58 |
| Phase 4 | 182 |
Therapeutic Areas
What is open in the Massachusetts General Hospital pipeline
336 recruiting of 2,032 indexed (17% open); 1,284 completed (63%).
Phase mix: 240 late (III/IV) vs 515 early (I/II) (early-phase heavy).
Top condition: Depression (29 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.